| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Accelerating glioblastoma therapeutics via venture philanthropy
|
Siah, Kien Wei
|
|
|
26 |
7 |
p. 1744-1749
|
artikel
|
| 2 |
Bioink: a 3D-bioprinting tool for anticancer drug discovery and cancer management
|
Tiwari, Arpita P.
|
|
|
26 |
7 |
p. 1574-1590
|
artikel
|
| 3 |
Contents page 1
|
|
|
|
26 |
7 |
p. i
|
artikel
|
| 4 |
Contents page 2
|
|
|
|
26 |
7 |
p. ii
|
artikel
|
| 5 |
Current trends in and future potential of crowdfunding to finance R&D of treatments for neglected tropical diseases
|
Benazzouz, Safouane M.
|
|
|
26 |
7 |
p. 1563-1568
|
artikel
|
| 6 |
Decoys as potential therapeutic tools for diabetes
|
Mahjoubin-Tehran, Maryam
|
|
|
26 |
7 |
p. 1669-1679
|
artikel
|
| 7 |
Effects on immunization of the physicochemical parameters of particles as vaccine carriers
|
Dong, Zirong
|
|
|
26 |
7 |
p. 1712-1720
|
artikel
|
| 8 |
Epigenetic regulation in macrophage migration inhibitory factor (MIF)-mediated signaling in cancer and inflammation
|
Osipyan, Angelina
|
|
|
26 |
7 |
p. 1728-1734
|
artikel
|
| 9 |
Granulocyte colony-stimulating factor in traumatic spinal cord injury
|
Aschauer-Wallner, Stephanie
|
|
|
26 |
7 |
p. 1642-1655
|
artikel
|
| 10 |
Longevity pharmacology comes of age
|
de Magalhães, João Pedro
|
|
|
26 |
7 |
p. 1559-1562
|
artikel
|
| 11 |
Long noncoding RNAs have pivotal roles in chemoresistance of acute myeloid leukemia
|
Izadirad, Mehrdad
|
|
|
26 |
7 |
p. 1735-1743
|
artikel
|
| 12 |
Myotonic dystrophy type 1 drug development: A pipeline toward the market
|
Pascual-Gilabert, Marta
|
|
|
26 |
7 |
p. 1765-1772
|
artikel
|
| 13 |
Neoteric solvents for the pharmaceutical industry: an update
|
Sekharan, Thenrajan Raja
|
|
|
26 |
7 |
p. 1702-1711
|
artikel
|
| 14 |
Nipping disease in the bud: nSMase2 inhibitors as therapeutics in extracellular vesicle-mediated diseases
|
Tallon, Carolyn
|
|
|
26 |
7 |
p. 1656-1668
|
artikel
|
| 15 |
Patenting biological simulations in drug discovery
|
Jones, Ian L.
|
|
|
26 |
7 |
p. 1557-1558
|
artikel
|
| 16 |
Pathophysiology and inhibition of cholesteryl ester transfer protein for prevention of cardiovascular diseases: An update
|
Banerjee, Surojit
|
|
|
26 |
7 |
p. 1759-1764
|
artikel
|
| 17 |
Quantum computing's potential for drug discovery: Early stage industry dynamics
|
Zinner, Maximillian
|
|
|
26 |
7 |
p. 1680-1688
|
artikel
|
| 18 |
Small-molecule modulators of the circadian clock: Pharmacological potentials in circadian-related diseases
|
Ribeiro, Rodrigo F.N.
|
|
|
26 |
7 |
p. 1620-1641
|
artikel
|
| 19 |
Solute carriers as potential oncodrivers or suppressors: their key functions in malignant tumor formation
|
Rashid, Khalid
|
|
|
26 |
7 |
p. 1689-1701
|
artikel
|
| 20 |
Strategies for drug target identification in Mycobacterium leprae
|
Acebrón-García-de-Eulate, Marta
|
|
|
26 |
7 |
p. 1569-1573
|
artikel
|
| 21 |
Targeting interleukin-6 to treat neuromyelitis optica spectrum disorders: Implications from immunology, the FcRn pathway and clinical experience
|
Sellner, Johann
|
|
|
26 |
7 |
p. 1591-1601
|
artikel
|
| 22 |
Targeting the endocannabinoid system in diabesity: Fact or fiction?
|
Deeba, Farah
|
|
|
26 |
7 |
p. 1750-1758
|
artikel
|
| 23 |
The emerging role of immune checkpoint inhibitors in the treatment of triple-negative breast cancer
|
Singh, Sima
|
|
|
26 |
7 |
p. 1721-1727
|
artikel
|
| 24 |
The era of gene therapy: From preclinical development to clinical application
|
Alhakamy, Nabil A.
|
|
|
26 |
7 |
p. 1602-1619
|
artikel
|
Tijdschrift beschrijving